Strive, Inc. (Nasdaq: ASST, SATA, SATS) just printed a third-quarter GAAP profit. The number is large. The operating business is not.
On November 6, 2026, Strive filed an Item 2.02 Form 8-K for the quarter ended September 30, 2026. The attached results, and the same-day Form 10-Q, show net income of $509.032 million. Almost all of that is a $533.697 million unrealized gain on digital assets carried at fair value. Investment advisory fees were $1.559 million. Medical device revenue was $1.133 million. Total revenue was $2.696 million.
That is the claim in one line: this is a bitcoin mark-to-market quarter, funded by preferred paper, not a cash-earnings beat from asset management.
What happened
The 10-Q is the document to keep. As of September 30, 2026, Strive held 28,000 bitcoin. Aggregate cost basis was $2.524811 billion. Fair value was $2.340192 billion, or $83,577 per bitcoin. Weighted average acquisition cost sat at $90,170. The stack was still underwater versus cost at quarter-end. The income statement still showed a huge gain because the mark moved up during the quarter from a lower print.
Purchases during the three months ended September 30, 2026, were 8,136 bitcoin at an average cost of $78,885 per bitcoin. For the nine months ended September 30, 2026, the company acquired 20,373 bitcoin. Then came the subsequent-events dump: from October 1, 2026, through October 30, 2026, Strive bought another 15,124 bitcoin at about $83,310 each, inclusive of fees and expenses. The bitcoin treasury totaled 43,124 bitcoin as of October 30, 2026. Cash and cash equivalents were $285.405 million at September 30 and $490.4 million at October 30. A position in Strategy Inc. variable-rate preferred (STRC) was marked at $50.172 million on the September 30 balance sheet and $50.1 million on October 30.
Bitcoin itself is not staging a breakout while this filing sits on the tape. The site CoinGecko snapshot used for desk prices put bitcoin at $75,813 as of 2026-11-07T23:54:49+00:00, with a 24-hour change of −0.12152%. Coinbase BTC-USD last traded at $75,710.15 at 2026-11-08T00:10:53Z, with the venue 24-hour range $75,452.88 to $76,152.43 on the exchange ticker. That is a grind under the September 30 mark of $83,577, which is why traders should not treat the $509 million as cash in the drawer.
The capital stack that paid for the coins is in the same 10-Q. During the third quarter Strive issued 14.4 million Class A shares for $271.6 million of aggregate gross proceeds under its at-the-market common program, and 5.1 million SATA shares for $511.2 million of aggregate gross proceeds under the SATA ATM. After quarter-end, on October 20, 2026, it completed a registered offering of 7,000,000 shares of 15.00% Series A perpetual SATS preferred for about $609.0 million of net proceeds. From October 1 through October 30 it also issued 5,330,150 Class A shares for $157.5 million gross, 1,089,555 SATA shares for $109.0 million gross, and 3,418 SATS shares for $0.3 million gross. As of October 30, 2026, Class A shares outstanding were 118,117,620, Class B 9,213,489, SATA 14,030,176, and SATS 7,003,418. SATA’s monthly regular dividend rate per annum was 13.00% as of that date.
Context
Strive describes itself as a structured finance company and institutional asset manager that uses bitcoin as the hurdle rate for capital. Strive Asset Management, an SEC-registered adviser and wholly owned subsidiary, managed over $2.9 billion in AUM as of September 30, 2026. That AUM line is real. It is also tiny next to a $2.340 billion bitcoin line and $1.210820 billion of SATA mezzanine equity (12,940,621 shares issued, $1.3 billion liquidation preference at September 30).
Preferred dividends on the quarter were $34.231 million. Net income attributable to common stockholders was $474.801 million, or $5.24 per diluted share, on 90,534,798 diluted weighted-average common shares. Non-GAAP “adjusted” income in the press release attached to the 8-K is not the object here. The GAAP path is enough: digital-asset fair-value accounting under ASU 2023-08 / ASC 350-60, with Coinbase quoted prices as the Level 1 input, pushes bitcoin’s tape directly into net income. When bitcoin rallies inside a quarter, Strive can print a profit while still sitting below lifetime cost. When bitcoin fades after the quarter, as the November 7–8 snapshot shows versus the $83,577 September 30 mark, that profit does not stay glued to the equity.
The medical-device stub left over from the Semler Scientific combination is a sideshow with a cost. Medical device revenue was $1.133 million in the quarter. Strive terminated research and development on an in-development device and took a $14.650 million impairment. Nine-month results also show a $66.704 million bargain-purchase gain on that merger and a $2.594 million loss on bitcoin posted as collateral under a Coinbase loan, plus $8.431 million of loss on extinguishment of debt. The 10-Q still says the bitcoin holdings in the treasury discussion are unencumbered as of the report. Read that as a statement about the reported stack, not a promise that every past loan facility has vanished from history.
This desk already treated an earlier Strive buy as paper-funded coins, not a cash dump, when the September 28, 2026 8-K added 1,107 bitcoin. The Q3 package is the same machine at a larger scale: ATM common, ATM SATA, then a 15% SATS deal, then more coins. The Bitcoin history page is the right hub if you need the asset’s cycle, not Strive’s ticker. For how we timestamp a tape like this, use how to read a crypto market snapshot. Live filings of this type sit with Bitcoin News.
One more structural point. SATA and SATS pay holders on a tight calendar (SATA is described as paying each business day). Those coupons are senior to common. Bitcoin Yield-style KPIs in the press release, which Strive itself warns are not yield in the ordinary sense, go up when preferred proceeds buy coins. The 10-Q is more honest than the marketing metric: mezzanine liquidation preference rose from $201.3 million at December 31, 2025, to $1.3 billion at September 30, 2026. Common equity is levered to bitcoin after that claim.
Our read
I am not treating $509 million as operating earnings, and I am not treating 43,124 bitcoin as proof that the treasury is “cheap” versus bitcoin. The range is the story in the coin, and the capital stack is the story in the stock.
Strive’s Q3 profit is almost entirely a fair-value bounce on a book that still shows cost ($90,170 average, $2.525 billion) above the September 30 mark ($83,577, $2.340 billion). The October add of 15,124 bitcoin at about $83,310 was paid for with SATS, SATA, and ATM common, not with $2.7 million of quarterly revenue. Prefer that reading until the next primary filing says otherwise.
Falsifiable claim: By 2026-12-15 23:59 UTC, Strive’s next Form 10-Q or a restating 8-K still reports 28,000 bitcoin held as of 2026-09-30 and a $533.697 million net unrealized gain on digital assets for the three months ended 2026-09-30. If either figure is restated to a different number without a dated correction, this mark-to-market read is wrong.
What to watch next
First, the November and December 8-K buy updates. The October 30 subsequent-event table already jumps the stack from 28,000 to 43,124. Another preferred or ATM print that does not show up as more coins would break the “issue paper, buy bitcoin” pattern we have been tracking since the 1,107 bitcoin note.
Second, the coupon versus the coin. SATS is a 15.00% perpetual. SATA was at a 13.00% annualized monthly regular rate as of October 30, 2026. Those rates are contractual. Bitcoin at $75,813 on the November 7 snapshot is not. If Strive keeps issuing 13–15% paper to buy an asset that is still below its $90,170 average cost, the common residual gets thinner even if BTC Yield slides look pretty.
Third, custody and liens. The 10-Q says bitcoin is marked off Coinbase Level 1 prices and that reported holdings in the treasury discussion are unencumbered. Watch the next 10-Q for any return of the Coinbase-loan collateral line or a new secured facility. A stack that is large on the dashboard and pledged in the footnotes is a different object.
Fourth, the medical-device runoff. A $14.650 million R&D impairment against $1.133 million of device revenue is the company telling you that stub is not the thesis. If a later filing restarts device spend as a growth story, that would be an update to this view, not the current one.
Until those prints move, treat the Q3 headline as a bitcoin mark and a preferred-funded add, then go back to the range in the coin.